✦ LIBER ✦

Pilot Phase I/II Study of New Salvage Therapy (CHASE) for Refractory or Relapsed Malignant Lymphoma

✍ Scribed by Michinori Ogura; Yoshitoyo Kagami; Hirofumi Taji; Ritsuro Suzuki; Kazuhisa Miura; Takahiro Takeuchi; Yasuo Morishima

Publisher: Carden Jennings Publishing
Year: 2003
Tongue: English
Weight: 105 KB
Volume: 77
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf02986620

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine, vinorelbine and prednisone

Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study

✍ Hannes Müller-Beißenhirtz; Christoph Kasper; Holger Nückel; Ulrich Dührsen 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 85 KB

Pilot phase II study of weekly chemother

Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 192 KB

Phase II study of arsenic trioxide and a

Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study

✍ JE Chang; PM Voorhees; JM Kolesar; HG Ahuja; FA Sanchez; GA Rodriguez; K Kim; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Arsenic trioxide (As 2 O 3 ) has established clinical activity in acute promyelocytic leukaemia and has pre-clinical data suggesting activity in lymphoid malignancies. Cell death from As 2 O 3 may be the result of oxidative stress. Agents which deplete intracellular glutathione, such as ascorbic aci

A phase II trial of oral etoposide with

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas

✍ Jorge E. Romaguera; M. Alma Rodriguez; Frederick B. Hagemeister; Peter McLaughli 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 491 KB

Ifosfamide/Carboplatin/Etoposide (ICE),

Ifosfamide/Carboplatin/Etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: A Pediatric Oncology Group phase II study

✍ Kung, Faith H.; Harris, Michael B.; Krischer, Jeffrey P. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

nary observations on ICE as salvaging therapy for refractory NHL are encouraging. More study is needed to confirm our findings and to delineate which subtypes of NHL are most responsive to ICE therapy.

Hyperthermia for the treatment of patien

Hyperthermia for the treatment of patients with malignant germ cell tumors : A Phase I/II study in ten children and adolescents with recurrent or refractory tumors

✍ Rüdiger Wessalowski; Heidi Kruck; Hildegard Pape; Thomas Kahn; Reinhart Willers; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 3 views

waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du ¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the